Intuitive Surgical (NASDAQ: ISRG) has delivered substantial long-term value to investors, with a $1,000 investment made two decades ago growing to $36,576.44 today. The surgical robotics company currently holds a market capitalization of $135.97 billion.

The stock’s performance highlights the power of compounded returns over extended periods. Intuitive Surgical generated an average annual return of 19.77% over the last 20 years. This figure represents an outperformance of 10.53% against the broader market on an annualized basis.

What the Numbers Show

The divergence between Intuitive Surgical’s total annualized return and its market outperformance reveals the baseline market performance during this period. By subtracting the 10.53% outperformance from the 19.77% total return, the implied average annual market return over this 20-year window was approximately 9.24%. This calculation underscores that while the broader market provided solid double-digit adjacent growth, Intuitive Surgical more than doubled that benchmark through superior operational execution and sector dominance.

The current share price stands at $379.50. This valuation reflects sustained investor confidence in the company’s da Vinci surgical system and its recurring revenue model from instruments and service contracts. The data illustrates how consistent high-single-digit to low-double-digit growth rates, when compounded over twenty years, can transform modest capital into significant wealth.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Intuitive Surgical Inc. (NASDAQ: ISRG) shares are trending in after-hours trading following disclosures of an insider sale and a new manufacturing expansion in Malaysia. The medical technology company's stock closed down 5.84% to $374.48 in regular session trading on Thursday.

Insider Transaction Details

A Securities and Exchange Commission filing revealed that Executive Vice President and Chief Manufacturing and Supply Chain Officer Mark Brosius sold shares over three days. Brosius sold 77 shares each on Monday, Tuesday, and Wednesday at prices ranging from $390.67 to $394.26.

The total transaction involved 231 shares worth approximately $90,777. These sales were executed under a pre-arranged trading plan scheduled to expire on Feb. 14, 2027.

Malaysia Manufacturing Expansion

Intuitive Surgical announced a lease agreement with Penang Development Corporation for a new manufacturing facility in Penang, Malaysia. The site covers 316,000 square feet and is expected to begin operations in 2028.

The facility aims to create 1,200 jobs by 2032, focusing on the production of surgical instruments and electromechanical devices for the da Vinci surgical system. Glenn Vavoso, Senior Vice President and President of Asia Pacific, stated that Asia Pacific represents a significant growth opportunity for robotic-assisted surgery.

Trading Metrics

Intuitive Surgical has a market capitalization of $132.30 billion. The stock traded near the lower end of its 52-week range, which spans from a low of $328.57 to a high of $603.88. Trading volume was slightly above average, with 3.97 million shares traded compared to an average of 3.70 million.

The Relative Strength Index (RSI) stands at 45.40. Over the past 12 months, the stock has fallen 20.30%. In August, Oppenheimer analyst Suraj Kalia upgraded the stock from Perform to Outperform, setting a price target of $500.